Este mensaje es el último que voy a enviar como moderador de la lista.
Desde que la lista nació hace un año, mis mensajes han pasado a ser
habituales y espero que útiles. Hace unas semanas, solicité a la Junta de
AES que la gestión de la lista fuera una actividad en la que hubiera
rotación.
A partir de ahora Beatriz González, de la Universidad de Las Palmas de Gran
Canaria toma el relevo. Estoy convencido que incluso mejorará la
experiencia que tenemos hasta ahora.
Saludos a todos,

Pere Ibern

**************************

SEMINARIO

El Seminario de Estudios Sociales de la Salud y los Medicamentos (SESAM), de
la Universidad Carlos III de Madrid, tiene por objetivo la educación de
postgrado y la investigación en el campo de las ciencias sociales aplicadas
a la salud y los medicamentos.

El "Seminario de Madrid", bajo los auspicios de la beca recibida por The
Merck Company Foundation, reúne a académicos y profesionales del sector para
discutir estudios de investigación y la difusión del conocimiento en estos
temas.

Les invitamos a asistir a la próxima sesión del "Seminario de Madrid":

Próxima sesión:
Ponente:   Alfonso Jiménez Palacios (Director Gerente de Atención Primaria
Área 1 de Madrid)
Título: "Incentivos a los médicos"
Fecha: Miércoles, 14 de enero de 2004
Lugar/  horario: Club de profesores (Rectorado, edif.8, planta baja,
Universidad Carlos III de Madrid, Avda. de Madrid 126, 28903 Getafe)
De las 15:15 a las 16:15 horas(*)
(*) De las 14:30 a las 15:15 se ofrecerá un pequeño tentempié con café.

Esperamos que esta información sea de su interés y deseamos que pueda
acompañarnos en éste y próximos eventos.

Reciba un cordial saludo,

Félix Lobo
Director Seminario de Estudios Sociales de Salud y Medicamentos

P.D: Se ruega tenga la amabilidad de confirmar la asistencia a la siguiente
dirección de correo electrónico: [log in para visualizar] o bien al teléfono (91)
624 95 55. A continuación le adjunto el plano necesario para facilitar su
acceso a las instalaciones universitarias en el campus de Getafe:
www.uc3m.es/uc3m/gral/IG/CA/situaget.html.


**********************
NERA Report

Fees for Medical Specialists: How Does the UK Compare?

British medical specialists employed by the National Health Service (NHS)
can operate as self-employed practitioners outside the NHS in order to
maximize and increase their incomes. However, the dynamics of how salaries
are set in the two sectors is unlikely to reflect a competitive market
equilibrium. While much has been written and discussed about specialists'
NHS salaries, highlighted during the debate over their new NHS contract,
far less has been written about how private incomes are determined. In this
report, NERA Associate Director Edward Bramley-Harker and Analyst Salman
Aslam compare the fees paid to specialists for their private work in the UK
with fees paid to specialists in the U.S., Canada, Germany, Spain and
Australia. The authors find that the fees paid to UK specialists are high
relative to those paid to physicians in other health systems. Learn more:
http://www.nera.com/_template.cfm?c=6167&o=6494.

*******************************
The pursuit of equity in NHS resource allocation: should morbidity replace
utilisation as the basis for setting health care capitations?

S. Asthana(a), A. Gibson(b), G. Moon(c), J. Dicker(d), P. Brigham(e)

Social Science and Medicine 2004; 58(3):539-551

Full text via ScienceDirect :

http://www.sciencedirect.com/science?
_ob=GatewayURL&_origin=CONTENTS&_method=citationSearch&_piikey=S027795360300
217X&_version=1&md5=2c4fa29a1f5b84f9e5d2038e01257b57



Abstract

Although the English NHS has been described as a world leader in pioneering
methods of distributing expenditure in relation to population needs,
concerns about the legitimacy of using the current  utilisation-based model
to allocate health service resources are mounting. In this paper, we
present a critical review of NHS resource allocation in England and
demonstrate the feasibility and impact of using direct health estimates as
a basis for setting health care capitations. Comparing target allocations
for the inpatient treatment of coronary heart disease in a sample of 34
primary care trusts in contrasting locations in England, we find that a
morbidity-based model would result in a significant shift in hospital
resources away from deprived areas, towards areas with older demographic
profiles and towards rural areas. Discussing the findings in relation to a
wider policy context that is generally concerned to direct more health care
resources towards the poor, the paper concludes by calling for greater
clarity between the goals of health care equity and health equity. Whilst
the former demands that the legitimate needs of demographically older
populations for more health care resources are acknowledged, the goal of
health equity requires real political commitment to resource broader social
policy initiatives.

*********************************
Health Affairs -- Table of Contents Alert

A new issue of Health Affairs has been made available:


January/February 2004; Vol. 23, No. 1

URL: http://content.healthaffairs.org/content/vol23/issue1/index.shtml?etoc


-----------------------------------------------------------------
From The Editor
-----------------------------------------------------------------

An Industry Under Siege Mounts Counterattack
John K. Iglehart
Health Affairs 23(1): 7-8
http://content.healthaffairs.org/cgi/content/full/23/1/7?etoc


-----------------------------------------------------------------
Industry Priorities
-----------------------------------------------------------------

Priorities In The Pharmaceutical Industry

Health Affairs 23(1): 9
http://content.healthaffairs.org/cgi/content/full/23/1/9?etoc


The Changing Structure Of The Pharmaceutical Industry
Iain M. Cockburn
Health Affairs 23(1): 10-22
http://content.healthaffairs.org/cgi/content/abstract/23/1/10?etoc


The Medicine Cabinet: What's In It, Why, And Can We Change The Contents?
Thomas W. Croghan and Patricia M. Pittman
Health Affairs 23(1): 23-33
http://content.healthaffairs.org/cgi/content/abstract/23/1/23?etoc


Access Versus Excess: Value-Based Cost Sharing For Prescription Drugs
J.D. Kleinke
Health Affairs 23(1): 34-47
http://content.healthaffairs.org/cgi/content/abstract/23/1/34?etoc


Market Structure And Drug Innovation
Fabio Pammolli and Massimo Riccaboni
Health Affairs 23(1): 48-50
http://content.healthaffairs.org/cgi/content/abstract/23/1/48?etoc


-----------------------------------------------------------------
Environment
-----------------------------------------------------------------

The Evolving Environment For Prescription Drugs

Health Affairs 23(1): 51
http://content.healthaffairs.org/cgi/content/full/23/1/51?etoc


The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons
For Policy
Daniel P. Carpenter
Health Affairs 23(1): 52-63
http://content.healthaffairs.org/cgi/content/abstract/23/1/52?etoc


Inside the Triple Helix: Technology Transfer And Commercialization In The
Life Sciences
Eric G. Campbell, Joshua B. Powers, David Blumenthal, and Brian Biles
Health Affairs 23(1): 64-76
http://content.healthaffairs.org/cgi/content/abstract/23/1/64?etoc


Defining The Balance Of Risk And Benefit In The Era Of Genomics And
Proteomics
Robert M. Califf
Health Affairs 23(1): 77-87
http://content.healthaffairs.org/cgi/content/abstract/23/1/77?etoc


-----------------------------------------------------------------
Medicare Challenge
-----------------------------------------------------------------

The Challenges Of A Medicare Drug Benefit

Health Affairs 23(1): 88
http://content.healthaffairs.org/cgi/content/full/23/1/88?etoc


How Much Should Medicare Pay For Drugs?
Joseph P. Newhouse
Health Affairs 23(1): 89-102
http://content.healthaffairs.org/cgi/content/abstract/23/1/89?etoc


Unique Issues Raised By Drug Benefit Design
Ernst R. Berndt
Health Affairs 23(1): 103-106
http://content.healthaffairs.org/cgi/content/abstract/23/1/103?etoc


An Information Infrastructure For The Pharmaceutical Market
Uwe E. Reinhardt
Health Affairs 23(1): 107-112
http://content.healthaffairs.org/cgi/content/abstract/23/1/107?etoc


Medicare Drug Coverage And Moral Hazard
Mark V. Pauly
Health Affairs 23(1): 113-122
http://content.healthaffairs.org/cgi/content/abstract/23/1/113?etoc


-----------------------------------------------------------------
Benefit Design
-----------------------------------------------------------------

Designing A Prescription Drug Benefit

Health Affairs 23(1): 123
http://content.healthaffairs.org/cgi/content/full/23/1/123?etoc


Evidence-Based And Value-Based Formulary Guidelines
Peter J. Neumann
Health Affairs 23(1): 124-134
http://content.healthaffairs.org/cgi/content/abstract/23/1/124?etoc


Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In
Medicaid
Stephen B. Soumerai
Health Affairs 23(1): 135-146
http://content.healthaffairs.org/cgi/content/abstract/23/1/135?etoc


-----------------------------------------------------------------
Health Tracking
-----------------------------------------------------------------

Health Spending Rebound Continues In 2002
Katharine Levit, Cynthia Smith, Cathy Cowan, Art Sensenig, Aaron
Catlin, and the Health Accounts Team
Health Affairs 23(1): 147-159
http://content.healthaffairs.org/cgi/content/abstract/23/1/147?etoc


Retail Prescription Drug Spending In The National Health Accounts
Cynthia Smith
Health Affairs 23(1): 160-167
http://content.healthaffairs.org/cgi/content/abstract/23/1/160?etoc


Are The Young Becoming More Disabled?
Darius N. Lakdawalla, Jayanta Bhattacharya, and Dana P. Goldman
Health Affairs 23(1): 168-176
http://content.healthaffairs.org/cgi/content/abstract/23/1/168?etoc


Improving Health With Tobacco Dollars From The MSA: The Arkansas Experience
Joseph W. Thompson, Fay W. Boozman, Shirley Tyson, Kevin W. Ryan,
Suzanne McCarthy, Ray Scott, and G. Richard Smith
Health Affairs 23(1): 177-185
http://content.healthaffairs.org/cgi/content/abstract/23/1/177?etoc


Do Consumer-Directed Health Benefits Favor The Young And Healthy?
Dwight McNeill
Health Affairs 23(1): 186-193
http://content.healthaffairs.org/cgi/content/abstract/23/1/186?etoc


The Changing Face Of Pharmacy Benefit Design
Jesse D. Malkin, Dana P. Goldman, and Geoffrey F. Joyce
Health Affairs 23(1): 194-199
http://content.healthaffairs.org/cgi/content/abstract/23/1/194?etoc


Clinical Use Of Medical Devices In The 'Bermuda Triangle'
Larry Kessler, Scott D. Ramsey, Sean Tunis, and Sean D. Sullivan
Health Affairs 23(1): 200-207
http://content.healthaffairs.org/cgi/content/abstract/23/1/200?etoc


-----------------------------------------------------------------
Narrative Matters
-----------------------------------------------------------------

As Drug Marketing Pays Off, My Mother Pays Up
Janet R. Gilsdorf
Health Affairs 23(1): 208-212
http://content.healthaffairs.org/cgi/content/full/23/1/208?etoc


Giveaway Drugs: Good Intentions, Bad Design
Buck Taylor
Health Affairs 23(1): 213-217
http://content.healthaffairs.org/cgi/content/full/23/1/213?etoc


-----------------------------------------------------------------
DataWatch
-----------------------------------------------------------------

Physicians' Views Of Formularies: Implications For Medicare Drug Benefit
Design
Bruce E. Landon, James D. Reschovsky, and David Blumenthal
Health Affairs 23(1): 218-226
http://content.healthaffairs.org/cgi/content/abstract/23/1/218?etoc


How Do Incentive-Based Formularies Influence Drug Selection And Spending
For Hypertension?
Sachin Kamal-Bahl and Becky Briesacher
Health Affairs 23(1): 227-236
http://content.healthaffairs.org/cgi/content/abstract/23/1/227?etoc


Costs Of Enrolling Children In Medicaid And SCHIP
Gerry Fairbrother, Melinda J. Dutton, Deborah Bachrach, Kerry-Ann
Newell, Patricia Boozang, and Rachel Cooper
Health Affairs 23(1): 237-243
http://content.healthaffairs.org/cgi/content/abstract/23/1/237?etoc


-----------------------------------------------------------------
GrantWatch
-----------------------------------------------------------------

The Continued Need For Independent Research On Prescription Drugs
John F. Hoadley
Health Affairs 23(1): 244-249
http://content.healthaffairs.org/cgi/content/abstract/23/1/244?etoc


Grants & Grant Outcomes

Health Affairs 23(1): 250-252
http://content.healthaffairs.org/cgi/content/full/23/1/250?etoc


-----------------------------------------------------------------
UpDate
-----------------------------------------------------------------

Reorganizing The National Institutes Of Health
Richard A. Rettig
Health Affairs 23(1): 257-262
http://content.healthaffairs.org/cgi/content/abstract/23/1/257?etoc


Publications & Reports

Health Affairs 23(1): 263-265
http://content.healthaffairs.org/cgi/content/full/23/1/263?etoc


-----------------------------------------------------------------
Book Reviews
-----------------------------------------------------------------

From Medicare To Medi-scare
Colin Gordon
Health Affairs 23(1): 266-267
http://content.healthaffairs.org/cgi/content/full/23/1/266?etoc


Conflicts Of Interest And Preserving The Objectivity Of Scientific Research
Leah Belsky and Ezekiel J. Emanuel
Health Affairs 23(1): 268-270
http://content.healthaffairs.org/cgi/content/full/23/1/268?etoc


Independent Living--In The Jungle Or The Zoo?
Robyn Stone
Health Affairs 23(1): 271-272
http://content.healthaffairs.org/cgi/content/full/23/1/271?etoc


-----------------------------------------------------------------
Letters
-----------------------------------------------------------------

Hospital Spending
Paul B. Ginsburg
Health Affairs 23(1): 273
http://content.healthaffairs.org/cgi/content/full/23/1/273?etoc


Better Health, Lower Spending
Kenneth G. Manton, David Shactman, and Stuart T. Altman
Health Affairs 23(1): 273-274
http://content.healthaffairs.org/cgi/content/full/23/1/273-a?etoc


The Uninsured And Hospital Use
Richard Siegrist, Catherine G. McLaughlin, and Karoline Mortensen
Health Affairs 23(1): 274-275
http://content.healthaffairs.org/cgi/content/full/23/1/274?etoc


Medicare Prospective Payment
James Bentley, Chantal Worzala, Jack Ashby, and Julian Pettengill
Health Affairs 23(1): 275-276
http://content.healthaffairs.org/cgi/content/full/23/1/275?etoc


Affordability Sensitive To Economic Growth Rates
Michael Schlander, Christian Thielscher, Oliver Schwarz, and Michael
E. Chernew
Health Affairs 23(1): 276-277
http://content.healthaffairs.org/cgi/content/full/23/1/276?etoc


Statement Of Ownership, Management, And Circulation
Judie Tucker
Health Affairs 23(1): 278
http://content.healthaffairs.org/cgi/content/full/23/1/278?etoc

----------------------------------------------------
Para darse de baja ECONSALUD pincha y envia el siguiente url
mailto:[log in para visualizar]
----------------------------------------------------